[1]
Preda, C.M., Marin, R.I., Becheanu, G., Neacsu, F., Manuc, T. and Manuc, M. 2021. Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection. Journal of Gastrointestinal and Liver Diseases. 30, 3 (Sep. 2021), 411–413. DOI:https://doi.org/10.15403/jgld-3923.